GSE209746
Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer
We performed RNA-seq on pre-treatment endoscopic biopsies from 114 patients, including 97 patients treated with NAT that qualified for outcome analyses We then performed gene expression profiling analysis using data obtained from RNA-seq Overall design: Comparative gene expression profiling analysis of RNA-seq data between CR/iCR patients and ssgsea analysis